You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
立方製藥(003020.SZ):擬申請將公司及立方藥業名下部分已有土地用途變更為科研用地
格隆匯 12-28 22:00

格隆匯 12 月 28日丨立方製藥(003020.SZ)公佈,公司因科研綜合樓項目建設需要,擬申請將公司及子公司安徽立方藥業有限公司(“立方藥業”)名下部分已有土地的用途由工業用地變更為科研用地。宗地基本情況如下:

(一)地塊一基本情況

土地使用權人:立方製藥;土地證號:合高新國用(2013)第002號;坐落:高新區望江西路與文曲路交口東南角;地類(用途):工業;使用權面積:16,090.298平方米;

(二)地塊二基本情況

土地使用權人:立方藥業;土地證號:合高新國用(2013)第003號;坐落:高新區望江西路與文曲路交口東南角;地類(用途):工業;使用權面積:16,460.66平方米。

公司擬將上述地塊一及地塊二中總面積為5281平方米(最終面積以土地管理部門出具的土地使用權證書記載為準)的地塊用途變更為科研用地,並補充繳納不超過人民幣800萬元(最終價格以公司與政府土地管理部門簽署的土地使用權出讓合同為準)的國有建設用地使用權出讓價款,該部分土地變更後的土地使用權人為立方製藥。

上述土地用途變更完成後,地塊一及地塊二的面積相應減少,但土地用途及使用權人不發生變更,各部分的最終面積以土地管理部門出具的土地使用權證書記載為準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account